Vascular disorder
Therapeutic area
Vascular Medicine
Rare disease
No
- Definition
- A general term used to describe any disease affecting blood vessels]. It includes vascular abnormalities caused by degenerative, metabolic and inflammatory conditions, embolic diseases, coagulative disorders, and functional disorders such as posteri or reversible encephalopathy syndrome.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Vascular disorder
- Therapeutic area
- Vascular Medicine
- vascular disorder
- disease of vasculature
- disease or disorder of vasculature
- disorder of vasculature
- Vascular Disease
- Vascular Diseases
- Vascular Disorders
- vasculature disease
- vasculature disease or disorder
- Vasculopathy
- Severity
- Unknown
- Cardiology
- Vascular Medicine
Sources for recorded values
- MONDO ID
- MONDO:0005385
- Parent condition
- MONDO:0004995
Related records
Broader conditions (4)
- Cardiovascular disorder
- Disease
- Disease by body system or component
- Human disease
Narrower conditions (846)
- Abdominal aortic aneurysm
- Abdominal cystic lymphangioma
- Aberrant subclavian artery
- ABeta amyloidosis, Arctic type
- ABeta amyloidosis, dutch type
- ABeta amyloidosis, Iowa type
- ABeta amyloidosis, Italian type
- ABetaA21G amyloidosis
- ABetaL34V amyloidosis
- Abnormal number of coronary ostia
- ABri amyloidosis
- Absence of innominate vein
- Absence of the pulmonary artery
- Acquired aneurysmal subarachnoid hemorrhage
- Acquired angioedema
- Acquired angioedema type 1
- Acquired angioedema type 2
- Acquired angioedema with C1Inh deficiency
- Acquired hemangioma
- Acquired purpura fulminans
Trials (2,084)
- 'Low-salt' Bread as a Means of Reducing Dietary Salt and Lowering Blood Pressure
- "SVEAT" Chest Pain Scoring System
- "Unifuzol®" in Patients With Peripheral Arterial Disease
- 10-Years Follow-up of the EXAMINATION Trial
- 11C-PIB PET Study in MESA at Columbia University
- 12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China
- 18F-S2P PET Imaging in the Evaluation of Large Artery Atherosclerosis
- 3D Contrast Enhanced Acoustic Perfusion Imaging in Adult After Subarachnoid Hemorrhage
- 480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions
- 4D-310 in Adults With Fabry Disease and Cardiac Involvement
- A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
- A Biomarker to Detect Salt Sensitivity
- A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
- A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese Population
- A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR) Angiography
- A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO)
- A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)
- A Clinical Trial of an Herbal Liquid Supplement - 'DBPS' for Managing Blood Pressure
- A Clinical Trial to Evaluate the Safety and Efficacy of IBS Angel in Patients With Pulmonary Artery Stenosis
- A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
Approved drugs (2)
- Idecabtagene vicleucel
- Iopanoic acid
Drugs in development (38)
- Acebutolol Phase 2
- Alirocumab Phase 2
- Ambrisentan Phase 3
- Amlodipine Phase 2
- Ascorbic acid Phase 2
- Aspirin Phase 3
- Atenolol Phase 3
- Atorvastatin Phase 2
- Bevacizumab Phase 2
- BMS-582949 Phase 2
- Calcium chloride Early phase 1
- Carvedilol Phase 1
- Chlorthalidone Phase 3
- Clevidipine Early phase 1
- Clopidogrel Phase 3
- Colchicine Phase 2
- Dexmedetomidine Early phase 1
- Doxazosin Phase 2
- Doxycycline Phase 2
- Enalapril Phase 2
Other linked drugs (2)
- L-citrulline
- Sildenafil